These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11122730)

  • 1. Cholesterol, stroke risk, and stroke prevention.
    Ansell BJ
    Curr Atheroscler Rep; 2000 Mar; 2(2):92-6. PubMed ID: 11122730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterol and stroke risk: a role for statins?].
    Devuyst G; Bogousslavsky J
    Schweiz Med Wochenschr; 2000 Aug; 130(33):1157-63. PubMed ID: 11005106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cholesterol and statins in stroke.
    Navi BB; Segal AZ
    Curr Cardiol Rep; 2009 Jan; 11(1):4-11. PubMed ID: 19091169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis.
    Giugliano RP; Pedersen TR; Saver JL; Sever PS; Keech AC; Bohula EA; Murphy SA; Wasserman SM; Honarpour N; Wang H; Lira Pineda A; Sabatine MS;
    Stroke; 2020 May; 51(5):1546-1554. PubMed ID: 32312223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol Lowering and Stroke: No Longer Room for Pleiotropic Effects of Statins - Confirmation from PCSK9 Inhibitor Studies.
    Salvatore T; Morganti R; Marchioli R; De Caterina R
    Am J Med; 2020 Jan; 133(1):95-99.e6. PubMed ID: 31301293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues.
    Watts GF; Burke V
    Curr Opin Lipidol; 1996 Dec; 7(6):341-55. PubMed ID: 9117137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study.
    Alemao E; Yin D; Sintonen H; Salomaa V; Jousilahti P
    Am J Cardiovasc Drugs; 2006; 6(5):349-55. PubMed ID: 17083270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial.
    Amarenco P; Goldstein LB; Messig M; O'Neill BJ; Callahan A; Sillesen H; Hennerici MG; Zivin JA; Welch KM;
    Stroke; 2009 Jul; 40(7):2486-92. PubMed ID: 19461031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).
    Mabuchi H; Kita T; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
    Circ J; 2002 Dec; 66(12):1096-100. PubMed ID: 12499612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statins for prevention of stroke?].
    Strandberg T
    Duodecim; 1999; 115(12):1277-8. PubMed ID: 11877827
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction.
    Amarenco P
    Neurology; 2001; 57(5 Suppl 2):S35-44. PubMed ID: 11552053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lowering cholesterol. New concepts with atorvastatin].
    Internist (Berl); 1997 Jan; 38(1 Suppl):1-8. PubMed ID: 9102396
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.
    Sarti C; Kaarisalo M; Tuomilehto J
    Drugs Aging; 2000 Jul; 17(1):33-51. PubMed ID: 10933514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
    Corvol JC; Bouzamondo A; Sirol M; Hulot JS; Sanchez P; Lechat P
    Arch Intern Med; 2003 Mar; 163(6):669-76. PubMed ID: 12639199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
    Bach LA; Cooper ME; O'Brien RC; Jerums G
    J Am Geriatr Soc; 1990 Jan; 38(1):10-4. PubMed ID: 2404052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet.
    Koh KK; Son JW; Ahn JY; Choi YM; Jin DK; Park GS; Choi IS; Sohn MS; Shin EK
    Coron Artery Dis; 2001 Jun; 12(4):305-11. PubMed ID: 11428539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol.
    Green R; Kwok S; Durrington PN
    QJM; 2002 Dec; 95(12):821-6. PubMed ID: 12454325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Powdered red yeast rice and plant stanols and sterols to lower cholesterol.
    Feuerstein JS; Bjerke WS
    J Diet Suppl; 2012 Jun; 9(2):110-5. PubMed ID: 22531006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.